What did BB say that isn’t true? He’s not down ramping or starting an argument. He’s speaking the truth as a shareholder.
Ex1 has been a massive disappointment in terms of shareprice since the second last capital raise. They over promised and have under delivered. If you look at the shareprice chart and think it hasn’t been a disappointment then we’re on different planets.
They need to do what they said they were close to a long time ago, land a deal.
- Forums
- ASX - By Stock
- TYP
- Ann: Exopharm Gains US Patent for LEAP Technology
Ann: Exopharm Gains US Patent for LEAP Technology, page-4
Featured News
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.10M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.6¢ | $297.0K | 6.063M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 249224 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 0.048 |
1 | 260000 | 0.047 |
1 | 54347 | 0.046 |
5 | 1069599 | 0.045 |
2 | 300000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 249224 | 2 |
0.050 | 158497 | 2 |
0.053 | 200759 | 2 |
0.054 | 285561 | 4 |
0.055 | 192266 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online